Global Scoliosis Management Research Report 2024: Market to Reach $3.8 Billion by 2030 – ResearchAndMarkets.com

Strong Focus on Minimally-Invasive Spine Surgeries and Increasing Use of Navigation and Robotics 

DUBLIN, June 4, 2024 – (BUSINESS WIRE) – The “Scoliosis Management – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.

Global Scoliosis Management Market to Reach $3.8 Billion by 2030

The global market for Scoliosis Management estimated at US$2.9 Billion in the year 2023, is projected to reach a revised size of US$3.8 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030.

The global scoliosis management market is projected to witness steady growth in 2023, driven by continuous innovations and advancements in the field. Key competitors’ market share highlights a competitive landscape with several leading global brands making significant impacts. North America holds a leadership position in the market, primarily due to advanced healthcare infrastructure and high awareness levels.

ThoracoLumboSacral Orthosis (TLSO), one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Cervical Thoracic Lumbar Sacral Orthosis (ctlso) segment is estimated at 3.2% CAGR for the next 8-year period. While Adolescent Idiopathic Scoliosis (AIS) remains the primary disease type segment. The pediatric/adolescent age group is the major demographic segment, and hospitals and ambulatory surgical centers (ASCs) claim the leading share in the market distribution.

Technological advances are a key trend propelling the scoliosis management market forward, with increasing R&D activity expected to spur further market expansion. However, the market faces several restraints and challenges, such as high costs and limited access to advanced treatments in developing regions. Recent market activities reflect a vibrant startup ecosystem contributing to market dynamism and innovation. As the market continues to evolve, global brands remain at the forefront, driving growth and development in scoliosis management solutions.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 4.3% CAGR

The Scoliosis Management market in the U.S. is estimated at US$1 Billion in the year 2023. China, the world’s second largest economy, is forecast to reach a projected market size of US$422.1 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 2.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Key Attributes:

Report AttributeDetails
No. of Pages297
Forecast Period2023 – 2030
Estimated Market Value (USD) in 2023$2.9 Billion
Forecasted Market Value (USD) by 2030$3.8 Billion
Compound Annual Growth Rate3.9%
Regions CoveredGlobal


  • Scoliosis: An Anomalous Lateral Curvature of Spine
  • Scoliosis Management/Treatment Options
  • Global Economic Update
  • Competition
  • Scoliosis Management – Global Key Competitors Percentage Market Share in 2023 (E)
  • Amazing Startup Ecosystem
  • Global Market Analysis and Prospects
  • Global Scoliosis Management Market to Witness Steady Growth, Driven by Innovations and Advancements
  • North America Shoulders Leadership Position in Global Scoliosis Management Market
  • ThoracoLumboSacral Orthosis (TLSO) Dominates the Market
  • AIS Remains Primary Disease Type Segment
  • Pediatric/Adolescent as Major Age Group Segment
  • Hospitals & ASCs Claim Leading Share
  • Technological Advances as Pulsating Trend Moves Scoliosis Management Market Forward
  • Increasing R&D Activity to Spur Market Expansion
  • Market Restraints
  • Market Challenges
  • Recent Market Activity


  • Rising Prevalence of Idiopathic & Congenital Scoliosis Drives Market Growth
  • Spinal Fusion Surgery Holds Strong Opportunities
  • Demand for Fusionless Scoliosis Surgery Increases
  • Vertebral Body Tethering Gains Traction
  • Schroth Therapy – A Useful Approach to Manage Scoliosis
  • Strong Focus on Minimally-Invasive Spine Surgeries and Increasing Use of Navigation and Robotics in Scoliosis Surgeries to Boost Prospects
  • Increasing Cases of Adult Scoliosis and Growing Aging Population to Propel the Adult Segment
  • Rise in Healthcare Expenditure to Drive Growth
  • Recent Technological Advancements/Innovations in the Scoliosis Management Market
  • Innovative Scoliosis Treatments for Young Children at the Duke Hospital
  • New Surgical Treatment Options for Scoliosis being Explored at the Philadelphia Hospital
  • New Satellite Rod-based Sequential Correction for Severe Rigid Spinal Deformity to Reduce Surgery Risks and Other Complications
  • Stereo-photogrammetric Technology, 3dMD, for Management of Scoliosis without Harmful X-Rays
  • ApiFix System for Correcting Moderate Scoliosis with Single Curves
  • Shriners Hospitals for Children’s The Tether, a Device for Scoliosis Treatment, Receives FDA Approval
  • Minimally Invasive Spine Surgeries to become Commonplace but Long Term Studies of Outcomes Essential for Wider Adoption
  • Disruptive Technologies in the Spine Space – A Review
  • 3D Printed Brace Holds Potential to Enhance Scoliosis Treatment


  • Aspen Medical Products, LLC
  • Bauerfeind AG
  • Boston Orthotics & Prosthetics
  • Chaneco
  • Enovis
  • Fited, Inc.
  • Horton’s Orthotics & Prosthetics
  • Lawall Prosthetics and Orthotics
  • Optec USA, Inc.
  • Orthotec
  • Ottobock SE & Co. KGaA
  • Spinal Technology Inc.
  • Trulife

For more information about this report visit https://www.researchandmarkets.com/r/s2wxco

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Tim Allen

Medtech leader with 19+ years of experience in medical device product development, manufacturing, and project management.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button